New! View global litigation for patent families

US20050233351A1 - Ultrasensitive immunoassays - Google Patents

Ultrasensitive immunoassays Download PDF

Info

Publication number
US20050233351A1
US20050233351A1 US11011438 US1143804A US20050233351A1 US 20050233351 A1 US20050233351 A1 US 20050233351A1 US 11011438 US11011438 US 11011438 US 1143804 A US1143804 A US 1143804A US 20050233351 A1 US20050233351 A1 US 20050233351A1
Authority
US
Grant status
Application
Patent type
Prior art keywords
antibodies
oligonucleotides
antigen
reagents
specific
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US11011438
Inventor
Ulf Landegren
Original Assignee
Ulf Landegren
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date

Links

Images

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay
    • G01N33/543Immunoassay; Biospecific binding assay with an insoluble carrier for immobilising immunochemicals
    • G01N33/54306Solid-phase reaction mechanisms
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813Hybridisation assays
    • C12Q1/6816Hybridisation assays characterised by the means of detection
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813Hybridisation assays
    • C12Q1/6816Hybridisation assays characterised by the means of detection
    • C12Q1/682Signal amplification
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/81Packaged device or kit
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/975Kit

Abstract

The present invention relates to an immunological test kit and immunoassay using a first immobilized antibody having affinity for a specific antigen. The invention is characterized by a second and third antibody being specific for different determinants of the antigen and modified with cross-linkable oligonucleotides. For detection, the oligonucleotides are amplified, whereby only such oligonucleotides will be amplified which have been cross-linked to each other. In this way unspecific background is avoided and detection is possible down to single molecules.

Description

    TECHNICAL FIELD
  • [0001]
    The present invention relates to ultrasensitive immunoassays. More specifically, it relates to immunological test kits and processes for immunological detection of a specific antigen. In the present invention, the fields of immunology and molecular genetics are combined.
  • BACKGROUND OF THE INVENTION
  • [0002]
    Immunoassays represent powerful tools to identify a very wide range of compounds, such as antigens and antibodies. Examples of immunoassays are ELISA (enzyme linked immunosorbent assay), EIA (enzyme immunoassay), and RIA (radio immunoassay). Common to all these immunoassays, is that detection sensitivity is limited by the affinity of typical antibodies.
  • [0003]
    With the prior art immunoassays, detection is not possible below a certain number of molecules, because the background, i.e. unspecifically bound material, interferes with the results. Detection of very low numbers of antigen is becoming increasingly important, especially for diagnostic applications. Therefore, further developments in sensitivity as well as specificity of immunological assays are desired.
  • [0004]
    Cantor et al, Science, Vol. 258, 2 Oct. 1992, have previously reported the attachment of oligonucleotides to antibodies in order to permit detection of such antibodies having bound antigen in immune reactions. A streptavidin-protein A chimera that posseses tight and specific binding affinity for both biotin and immunoglobulin G was used to attach biotinylated DNA specifically to antigen-monoclonal antibody complexes that had been immobilized on microtiter plate wells. Then, a segment of the attached DNA was amplified by PCR (Polymerase Chain Reaction). Analysis of the PCR products by agarose gel electrophoresis after staining with ethidium bromide allowed detection of 580 antigen molecules (9.6×10−22 moles) which is a significant improvement compared to, for example, conventional ELISA.
  • [0005]
    However, in Cantor et al., the labeled DNA-antibody complexes are assembled in situ during the assay. This can create variable stoichiometry in the assembly of the components and in the attachment of the DNA label. Moreover, extra steps are required for addition of biotinylated reagents and binding proteins. Numerous wash steps are also needed to remove excess reagents and to free assay components of non-specifically bound reagents.
  • [0006]
    Hendrickson et al., Nucleic Acids Research, 1995, Vol 23, No.3, report an advancement of the Cantor et al. assay that reduces complexity. This is achieved through labeling antibody with DNA by direct covalent linkage of the DNA to the antibody. In this approach, the analyte specific antibody and the 5′ amino modified DNA oligonucleotide are independently activated by means of separate heterobifunctional cross-linking agents. The activated antibody and DNA label are then coupled in a single spontaneous reaction.
  • [0007]
    International patent publication no. WO 91/17442 describes a molecular probe for use as a signal amplifier in immunoassays for detecting i.a. antigens. The probe comprises an antibody, a double stranded polynucleotide functioning as a promoter for a DNA dependend RNA polymerase, and a single or double stranded template for the promoter. The transcription product is quantified and correlated to the amount of present antigen in a sample.
  • [0008]
    However, in all three of the above described immunoassays the attached DNA is only used as a marker by being amplified to detectable levels. There is no distinction between oligonucleotides attached to antibodies having bound antigen and oligonucleotides attached to antibodies not having bound antigen, i.e. those being non-specifically trapped. Non-specifically trapped antibodies give rise to an undesired background signal and limits the minimun number of antigen molecules that can be detected and it will not be possible to distinguish between false positive and true positive results below a certain number of antigen molecules. Commonly, solid supports such as microtiter plates, are used for the reactions. According to prior art, there will always be an excess of oligonucleotide-labeled antibody that cannot be removed from the solid support by adding background-lowering agents and by repeated wash steps.
  • SUMMARY OF THE INVENTION
  • [0009]
    The present invention enables detection of extremely low numbers of antigenic molecules, even down to a single molecule. The invention provides reliable immunoassays in situations where insufficient numbers of antigens are available for conventional assays.
  • [0010]
    According to a first aspect of the invention, there is provided an immunological test kit comprising a first immobilized reagent having affinity for a specific macromolecule, such as a protein. Furthermore, the test kit comprises a second and a third affinity reagent specific for different determinantes of said macromolecule, and modified with crosslinkable compounds enabling a) conjugation of said second and third affinity reagent only when both are bound to the said, same macromolecule, and b) detection by amplification.
  • [0011]
    According to a preferred embodiment of the invention, the affinity reagents are antibodies and the crosslinkable compounds are oligonucleotide extensions attached to the second and third antibody, respectively. The macromolecule is in this case a specific antigen.
  • [0012]
    According to a second aspect of the invention there is provided an immundassay for detection of a specific antigen, comprising the following steps:
    • a) contacting a sample suspected of containing said specific antigen with a first antibody linked to a solid support, said first antibody being specific for a first epitope on the antigen,
    • b) washing off excess reagents,
    • c) incubating with a solution of a second and a third antibody specific for a second and third epitope of said antigen, and modified with crosslinkable oligonucleotides enabling conjugation of said second and third antibody when both are bound to the said, same antigen,
    • d) washing off excess reagents,
    • e) amplifying said crosslinked oligonucleotides, and
    • f) detecting the amplified products.
  • [0019]
    Products from the amplification reaction only result when two antibodies, i.e. the second and the third, have bound to the same antigen. Thus, amplification is specific for antibodies having bound to antigen. Non-specifically trapped antibodies do not give rise to any signal.
  • DETAILED DESCRIPTION OF THE INVENTION
  • [0020]
    The present invention will be described more detailed below with reference to the accompanying drawings, in which
  • [0021]
    FIG. 1 is a schematic view of the principles of the immunoassay according to the invention, and
  • [0022]
    FIG. 2 shows chemical coupling of amino-modified oligonucleotides to macromolecules.
  • [0023]
    In FIG. 1 there is shown an immobilized antibody to a specific antigen applied together with two other antibodies, specific for other determinants on the same antigen. Besides antibodies other specifically interacting species with a known affinity, such as lectins, receptors, single chain antibodies, cofactors, oligonucleotides and other non-proteins, can be used in the invention.
  • [0024]
    The interacting species are modified with crosslinkable compounds in the form of an interacting pair, preferably short oligonucleotide extentions. Upon the coordinated binding of several so modified antibodies, oligonucleotides of neighbouring antibodies are conjugated to each other. The conjugation may or may not necessitate an enzymatic ligation step depending on the orientation of the oligonucleotide extensions.
  • [0025]
    If the conjugation is between free 3′ and 5′ ends ligation is necessary, such as by T4 RNA ligase or T4 DNA ligase. To facilitate the conjugation, it is convenient to use a stretch of oligonucleotides base pairing to and, thereby, juxtaposing the free ends of the oligonucleotides and permitting their joining through ligation.
  • [0026]
    If the conjugation is between free 3′ ends these have to be designed to be mutually complementary to achieve base pairing and initiation of DNA synthesis extending the 3′ ends of the the molecules.
  • [0027]
    Thus, only in those cases where the antibodies are brought close enough through binding to the same antigen molecule can the oligonucleotides be ligated. Ligated molecules subsequently serve as templates for nucleic acid amplification reactions.
  • [0028]
    In FIG. 2, there is shown a suitable way to attach the oligonucleotide extension to the antibodies. First, the oligonucleotides are terminally amino-modified and then attached to primary amines on the antibodies via disulphide bonds, e.g. according to the technique of Chue and Orgel, Nucleic Acid Research, Vol. 16, No. 9, 1988. Another way is by direct covalent coupling as described by Hendrickson et el., supra.
  • [0029]
    The antibodies used in the invention can be polyclonal, monoclonal or single chain antibodies produced by bacteriophages. In the latter case, it is possible to have antibodies equipped with an oligonucleotide binding part, rendering the above coupling step between antibody and oligonucleotide unnecessary.
  • [0030]
    The amplification technique to obtain detectable products is, for example, PCR (Polymerase Chain Reaction), LCR (Ligase Chain Reaction), SDA (Strand Displacement Amplification) bacteriophage Qβ replication, and 3SR (Self-Sustained Synthetic Reaction), of which the latter three methods do not require temperature cycling.
  • [0031]
    The method for detecting amplified products can, for example, be direct incorporation of a label, such as radioisotopes, fluorochromes, and enzymes, into the amplified products with the use of label-conjugated primers or nucleotides. Preferably, the accumulation of amplified products is monitored via the fluorescence from intercalating dyes, such as propidium iodide, etidium bromide and SYBR™ green from Molecular Probes.
  • [0032]
    The invention is not restricted to detection of any special kind of macromolecule, such as an antigen; the only criterion it has to fulfil is that it must be able to simultaneously bind three antibodies/affinity reagents. In the case where the affinity reagents are antibodies, the three antibodies are specific for different epitopes on the antigen. By biosensor analysis, it is possible to assure that the antibodies do not bind to overlapping epitopes on the antigen.
  • [0033]
    Examples of macromolecules are human myoglobin and human growth hormone. Ultrasensitive assays for growth hormone will have significant value in clinical situations where hormone levels are undetectable by prior art assays.
  • [0034]
    The invention will now be described below in a non-limiting Example.
  • EXAMPLE
  • [0035]
    Immunoglobulins were modified in a reaction with SPDP (3-(-pyridyldithio)propionic acid N-hydroxysuccinimide ester, from Pharmacia Biotech) according to the manufacturer's suggestions. Oligonucleotides were thiolated, either through the addition of a suitable phosphoramidite according to Connolly (Connolly B A, Nucl. Acid. Res. 1987 15:3131), or 3′aminomodified oligonucleotides were reacted with SPDP, followed by reduction of the dithiopyridyl bond, using dithiothreitol.
  • [0036]
    SPDP-modified antibodies were incubated with three equivalents of SH-containing oligonucleotides at 4° C. over night. The reaction mixture was separated using a Zorbax HPLC gel filtration column. Residual free antibody were removed from the isolated conjugate by ion exchange MonoQ FPLC separation.
  • [0037]
    The two oligonucleotides used to conjugate the antibodies were Oligo 1: 5′Tr S C3-ATA GAC TGA GCG TGG ACA TTA ATA TGT ACG TAG GCT TAA TTG AGT 3′ and Oligo 2: 5′P ATG TAC GAC CCG TAG ATA TTA TCA TAC TGG CAT GGG CAT GAT GAA CAT C-NHSPDP T3′
  • [0038]
    The immune test was performed by first binding 1 μg of biotinylated antibody (#1) to individual streptavidin-coated prongs on a manifold support. [Parik et al., Anal. Biochem; (1993) 211: 144-150B]. After washes using PBS (phosfhate buffered saline) with 0.5% Tween 20, the prongs were lowered into solutions of antigen (myoglobin) at variable concentrations. After further washes, the supports with bound antigen were incubated in a solution of two oligonucleotide-conjugated antibodies #2 and #3 at 5 ng each per reaction. The supports were washed, an oligonucleotide complementary to the free ends of the antibody-conjugated oligonucleotides was added (4 pmol per reaction, 540 CTA CGG GTC GTA CAT ACT CAA TTA AGC GTA 3′), and the ends of oligonucleotides on nearby antibodies were joined covalently by ligation at 37° C. for 30 min using 1 U of T4 DNA ligase. The supports were then washed in a standard PCR buffer, and the supports were added as templates in a PCR mix, including two primers specific for sequences located at either side of the ligation junction (5′TTA ATG GCG AG 3′) and Taq polymerase. After two cycles, the supports were removed and the amplification was continued for 26 more cycles. Amplification products were examined by separation in an agarose gel and ethidium bromide staining.

Claims (15)

  1. 1. Reagents for use in an assay for detection of a macromolecule comprising two affinity reagents, each reagent being specific for a different determinant of said macromolecule, and each reagent having attached thereto an oligonucleotide which is conjugatable to the oligonucleotide attached to the other of said two reagents, wherein said oligonucleotides are conjugatable by means of ligation or hybridization to each other only when said affinity reagents have became bound to the same said macromolecule and wherein said conjugated oligonucleotides may then serve as a template for a nucleic acid amplification reaction, for detection of said macromolecule.
  2. 2. The reagents of claim 1, wherein said oligonucleotides conjugate through
    i) hybridization of an oligonucleotide complementary to the conjugatable oligonucleotides;
    ii) hybridization of the conjugatable oligonucleotides to each other; or
    iii) ligation of the oligonucleotides.
  3. 3. The reagents of claim 1, wherein said macromolecule is a protein.
  4. 4. The reagents according to claim 1, wherein the reagents are antibodies.
  5. 5. The reagents of claim 1, wherein said reagents are polyclonal antibodies, monoclonal antibodies or single chain antibodies.
  6. 6. The reagents according to claim 1, wherein the oligonucleotides are complementary to each other.
  7. 7. The reagents of claim 1, wherein said oligonucleotides have complementary 3′ ends.
  8. 8. A method for detection of a macromolecule, which comprises binding said macromolecule to a first affinity reagent having affinity for said macromolecule, said first affinity reagent being specific for a first determinant of said macromolecule;
    incubating said first affinity reagent-bound macromolecule with said detection reagents of claim 1, specific for second and third determinants of said macromolecule, wherein said oligonucleotides conjugate to each other by hybridization or ligation when said detection reagents are both bound to said macromolecule;
    amplifying said conjugated oligonucleotides; and
    detecting the amplified products.
  9. 9. The method of claim 8, wherein said first affinity reagent is immobilized.
  10. 10. The method of claim 8, wherein said oligonucleotides conjugate through
    i) hybridization of an oligonucleotide complementary to the conjugatable oligonucleotides;
    ii) hybridization of the conjugatable oligonucleotides to each other; or
    iii) ligation of the oligonucleotides.
  11. 11. The method according to claim 8, wherein the conjugation occurs through hybridization of an oligonucleotide complementary to the conjugatable oligonucleotides.
  12. 12. The method according to claim 8, wherein the conjuation occurs through hybridization of the conjugatable oligonucleotides to each other.
  13. 13. The method according to claim 11, wherein the conjugation occurs through ligation of the oligonucleotides.
  14. 14. The method claim 8, wherein said affinity reagents are antibodies.
  15. 15. The method of claim 8, wherein said affinity reagents are polyclonal antibodies, monoclonal antibodies or single chain antibodies.
US11011438 1995-06-16 2004-12-15 Ultrasensitive immunoassays Abandoned US20050233351A1 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
SE9502196-0 1995-06-16
SE9502196 1995-06-16
US08981310 US6878515B1 (en) 1995-06-16 1996-06-14 Ultrasensitive immunoassays
PCT/SE1996/000779 WO1997000446A1 (en) 1995-06-16 1996-06-14 Immunoassay and kit with two reagents that are cross-linked if they adhere to an analyte
US11011438 US20050233351A1 (en) 1995-06-16 2004-12-15 Ultrasensitive immunoassays

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11011438 US20050233351A1 (en) 1995-06-16 2004-12-15 Ultrasensitive immunoassays

Publications (1)

Publication Number Publication Date
US20050233351A1 true true US20050233351A1 (en) 2005-10-20

Family

ID=20398643

Family Applications (2)

Application Number Title Priority Date Filing Date
US08981310 Expired - Fee Related US6878515B1 (en) 1995-06-16 1996-06-14 Ultrasensitive immunoassays
US11011438 Abandoned US20050233351A1 (en) 1995-06-16 2004-12-15 Ultrasensitive immunoassays

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US08981310 Expired - Fee Related US6878515B1 (en) 1995-06-16 1996-06-14 Ultrasensitive immunoassays

Country Status (6)

Country Link
US (2) US6878515B1 (en)
EP (1) EP0832431B1 (en)
JP (1) JP4091113B2 (en)
CA (1) CA2224674C (en)
DE (2) DE69614539D1 (en)
WO (1) WO1997000446A1 (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080305479A1 (en) * 2006-12-05 2008-12-11 Sequenom, Inc. Detection and quantification of biomolecules using mass spectrometry
US20090111712A1 (en) * 2006-12-05 2009-04-30 Sequenom, Inc. Detection and quantification of biomolecules using mass spectrometry
CN103454427A (en) * 2012-06-03 2013-12-18 河北省健海生物芯片技术有限责任公司 Method for detecting trace protein in blood by utilizing antibody-nucleic acid combined amplification technology
WO2014210376A1 (en) * 2013-06-27 2014-12-31 The Board Of Trustees Of The Leland Stanford Junior University Dna-conjugated antibodies for improved antibody affinity and reduced antibody cross reactivity
US9404150B2 (en) 2007-08-29 2016-08-02 Sequenom, Inc. Methods and compositions for universal size-specific PCR

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6878515B1 (en) * 1995-06-16 2005-04-12 Ulf Landegren Ultrasensitive immunoassays
US6558928B1 (en) * 1998-03-25 2003-05-06 Ulf Landegren Rolling circle replication of padlock probes
JP2002517206A (en) * 1998-06-04 2002-06-18 バクスター アー.ゲー. Methods for determining the antigen
US7306904B2 (en) 2000-02-18 2007-12-11 Olink Ab Methods and kits for proximity probing
EP1255861B1 (en) * 2000-02-18 2008-07-23 Olink AB Methods and kits for proximity probing
US20040229294A1 (en) 2002-05-21 2004-11-18 Po-Ying Chan-Hui ErbB surface receptor complexes as biomarkers
GB0118959D0 (en) 2001-08-03 2001-09-26 Nilsson Mats Nucleic acid amplification method
WO2003029489A1 (en) * 2001-10-03 2003-04-10 Iseao Technologies Limited Methods for detection of target molecules and molecular interactions
JP5117719B2 (en) 2003-04-18 2013-01-16 ベクトン・ディキンソン・アンド・カンパニーBecton, Dickinson And Company Immune amplification
US20050095627A1 (en) * 2003-09-03 2005-05-05 The Salk Institute For Biological Studies Multiple antigen detection assays and reagents
US7402399B2 (en) 2003-10-14 2008-07-22 Monogram Biosciences, Inc. Receptor tyrosine kinase signaling pathway analysis for diagnosis and therapy
CA2544577C (en) 2003-12-01 2013-01-08 Dako Denmark A/S Methods and compositions for immuno-histochemical detection
EP1692486B1 (en) * 2003-12-12 2015-10-28 Saint Louis University Biosensors for detecting macromolecules and other analytes
US7811809B2 (en) * 2005-06-15 2010-10-12 Saint Louis University Molecular biosensors for use in competition assays
US8956857B2 (en) * 2005-06-06 2015-02-17 Mediomics, Llc Three-component biosensors for detecting macromolecules and other analytes
US7795009B2 (en) * 2005-06-15 2010-09-14 Saint Louis University Three-component biosensors for detecting macromolecules and other analytes
US7595160B2 (en) 2004-01-13 2009-09-29 U.S. Genomics, Inc. Analyte detection using barcoded polymers
WO2005067692A3 (en) 2004-01-13 2005-09-29 Us Genomics Inc Detection and quantification of analytes in solution using polymers
US7618780B2 (en) * 2004-05-20 2009-11-17 Trillion Genomics Limited Use of mass labelled probes to detect target nucleic acids using mass spectrometry
WO2005123963A3 (en) * 2004-06-14 2006-06-08 Univ Leland Stanford Junior Methods and compositions for use in analyte detection using proximity probes
US8835186B2 (en) 2004-11-03 2014-09-16 Iris International, Inc. Microbubbles for affinity separation
ES2352041T5 (en) 2004-11-03 2014-12-22 Iris International, Inc. homogeneous detection of analytes
US20060204999A1 (en) * 2005-03-14 2006-09-14 Stephen Macevicz Detecting molecular complexes
EP1907410B1 (en) 2005-06-10 2012-07-04 Saint Louis University Methods for the selection of aptamers
US7883848B2 (en) * 2005-07-08 2011-02-08 Olink Ab Regulation analysis by cis reactivity, RACR
GB0605584D0 (en) * 2006-03-20 2006-04-26 Olink Ab Method for analyte detection using proximity probes
US8778846B2 (en) * 2006-12-04 2014-07-15 General Electric Company Composition, device and associated method
WO2010059820A1 (en) 2008-11-21 2010-05-27 Saint Louis University Biosensor for detecting multiple epitopes on a target
WO2010107946A3 (en) * 2009-03-18 2011-02-24 Sequenom, Inc. Use of thermostable endonucleases for generating reporter molecules
WO2010127186A1 (en) 2009-04-30 2010-11-04 Prognosys Biosciences, Inc. Nucleic acid constructs and methods of use
EP2534266B1 (en) 2010-02-12 2016-07-06 Saint Louis University Molecular biosensors capable of signal amplification
GB201004292D0 (en) 2010-03-15 2010-04-28 Olink Ab Assay for localised detection of analytes
CN105385756A (en) 2010-04-05 2016-03-09 普罗格诺西斯生物科学公司 Spatially encoded biological assays
GB201011971D0 (en) 2010-07-15 2010-09-01 Olink Ab Methods and product
WO2012049316A1 (en) 2010-10-15 2012-04-19 Olink Ab Dynamic range methods
WO2012057689A1 (en) * 2010-10-29 2012-05-03 Ge Healthcare Bio-Sciences Ab Proximity ligation technology for western blot applications
GB201101621D0 (en) 2011-01-31 2011-03-16 Olink Ab Method and product
GB201107863D0 (en) 2011-05-11 2011-06-22 Olink Ab Method and product
GB201108678D0 (en) 2011-05-24 2011-07-06 Olink Ab Multiplexed proximity ligation assay
KR20150023906A (en) * 2012-06-27 2015-03-05 에프. 호프만-라 로슈 아게 Method for the selection and production of tailor-made, selective and multi-specific therapeutic molecules comprising at least two different targeting entities and uses thereof
JP2016500511A (en) 2012-09-14 2016-01-14 エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft Method and use thereof for producing and selecting a molecule comprising at least two different entities
US20160369321A1 (en) 2012-11-14 2016-12-22 Olink Ab RCA Reporter Probes and Their Use in Detecting Nucleic Acid Molecules
CA2904181A1 (en) 2013-03-13 2014-10-09 Anahit Aghvanyan Improved assay methods
WO2014143623A1 (en) 2013-03-15 2014-09-18 The Lubrizol Corporation Heavy metal free cpvc compositions
US9593364B2 (en) 2013-05-21 2017-03-14 Src, Inc. Detecting a target molecule in a sample using a dual-antibody quantitative fluorescence-based detection method
WO2014210223A1 (en) 2013-06-25 2014-12-31 Prognosys Biosciences, Inc. Spatially encoded biological assays using a microfluidic device
WO2017053905A1 (en) 2015-09-24 2017-03-30 Abvitro Llc Affinity-oligonucleotide conjugates and uses thereof

Citations (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2079172A (en) * 1934-02-28 1937-05-04 Chandler & Price Co Platen printing press
US4563417A (en) * 1984-08-31 1986-01-07 Miles Laboratories, Inc. Nucleic acid hybridization assay employing antibodies to intercalation complexes
US4690890A (en) * 1984-04-04 1987-09-01 Cetus Corporation Process for simultaneously detecting multiple antigens using dual sandwich immunometric assay
US4748111A (en) * 1984-03-12 1988-05-31 Molecular Diagnostics, Inc. Nucleic acid-protein conjugate used in immunoassay
US4824775A (en) * 1985-01-03 1989-04-25 Molecular Diagnostics, Inc. Cells labeled with multiple Fluorophores bound to a nucleic acid carrier
US4988617A (en) * 1988-03-25 1991-01-29 California Institute Of Technology Method of detecting a nucleotide change in nucleic acids
US5011771A (en) * 1984-04-12 1991-04-30 The General Hospital Corporation Multiepitopic immunometric assay
US5026653A (en) * 1985-04-02 1991-06-25 Leeco Diagnostic, Inc. Scavenger antibody mixture and its use for immunometric assay
US5384255A (en) * 1993-06-21 1995-01-24 Rappaport Family Institute For Research In The Medical Sciences Ubiquitin carrier enzyme E2-F1, purification, production, and use
US5415839A (en) * 1993-10-21 1995-05-16 Abbott Laboratories Apparatus and method for amplifying and detecting target nucleic acids
US5635602A (en) * 1993-08-13 1997-06-03 The Regents Of The University Of California Design and synthesis of bispecific DNA-antibody conjugates
US5652107A (en) * 1993-01-15 1997-07-29 The Public Health Research Institute Of The City Of New York, Inc. Diagnostic assays and kits for RNA using RNA binary probes and a ribozyme ligase
US5656731A (en) * 1987-10-15 1997-08-12 Chiron Corporation Nucleic acid-amplified immunoassay probes
US5667974A (en) * 1995-06-07 1997-09-16 Abbott Laboratories Method for detecting nucleic acid sequences using competitive amplification
US5693764A (en) * 1994-03-11 1997-12-02 The University Of Kentucky Research Foundation Nucleotide or nucleoside photoaffinity compound modified antibodies, methods for their manufacture and use thereof as diagnostics and therapeutics
US5759773A (en) * 1993-01-15 1998-06-02 The Public Health Research Institute Of The City Of New York, Inc. Sensitive nucleic acid sandwich hybridization assay
US5780231A (en) * 1995-11-17 1998-07-14 Lynx Therapeutics, Inc. DNA extension and analysis with rolling primers
US5804384A (en) * 1996-12-06 1998-09-08 Vysis, Inc. Devices and methods for detecting multiple analytes in samples
US5812272A (en) * 1997-01-30 1998-09-22 Hewlett-Packard Company Apparatus and method with tiled light source array for integrated assay sensing
US5814492A (en) * 1995-06-07 1998-09-29 Abbott Laboratories Probe masking method of reducing background in an amplification reaction
US5830670A (en) * 1988-12-21 1998-11-03 The General Hospital Corporation Neural thread protein gene expression and detection of Alzheimer's disease
US5876976A (en) * 1990-05-01 1999-03-02 Amgen Inc. Method for reducing carryover contamination in an amplification procedure
US5919626A (en) * 1997-06-06 1999-07-06 Orchid Bio Computer, Inc. Attachment of unmodified nucleic acids to silanized solid phase surfaces
US5962223A (en) * 1984-12-13 1999-10-05 The Perkin-Elmer Corporation Detection of specific sequences in nucleic acids
US5985548A (en) * 1993-02-04 1999-11-16 E. I. Du Pont De Nemours And Company Amplification of assay reporters by nucleic acid replication
US6143508A (en) * 1989-06-29 2000-11-07 Rhone-Poulenc Rorer Pharmaceuticals Inc. Device and process for cell capture and recovery
US6235472B1 (en) * 1994-02-16 2001-05-22 Ulf Landegren Nucleic acid detecting reagent
US20020051986A1 (en) * 2000-06-13 2002-05-02 Luis Baez Method for the detection of an analyte by means of a nucleic acid reporter
US20020064779A1 (en) * 2000-02-18 2002-05-30 Ulf Landegren Methods and kits for proximity probing
US6558928B1 (en) * 1998-03-25 2003-05-06 Ulf Landegren Rolling circle replication of padlock probes
US20030148335A1 (en) * 2001-10-10 2003-08-07 Li Shen Detecting targets by unique identifier nucleotide tags
US20030207300A1 (en) * 2000-04-28 2003-11-06 Matray Tracy J. Multiplex analytical platform using molecular tags
US20040038200A1 (en) * 2000-07-11 2004-02-26 Wilson Stuart Mark Distinguishing molecular forms
US20040234966A1 (en) * 2003-05-23 2004-11-25 Applera Corporation Ionic liquid apparatus and method for biological samples
US20050009050A1 (en) * 2003-04-18 2005-01-13 James Nadeau Immuno-amplification
US6878515B1 (en) * 1995-06-16 2005-04-12 Ulf Landegren Ultrasensitive immunoassays
US20050287528A1 (en) * 2002-04-04 2005-12-29 Mount Sinai Hospital Methods for detecting ovarian cancer

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5079172A (en) * 1988-11-04 1992-01-07 Board Of Trustees Operating Michigan State University Method for detecting the presence of antibodies using gold-labeled antibodies and test kit
EP0528870B1 (en) 1990-05-04 1998-12-02 Chiron Corporation Protein-nucleic acid probes and immunoassays using same
EP1018649A3 (en) * 1992-03-31 2000-11-29 Abbott Laboratories Immunochromatographic device and method for multiplex detection of multiple analytes

Patent Citations (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2079172A (en) * 1934-02-28 1937-05-04 Chandler & Price Co Platen printing press
US4748111A (en) * 1984-03-12 1988-05-31 Molecular Diagnostics, Inc. Nucleic acid-protein conjugate used in immunoassay
US4690890A (en) * 1984-04-04 1987-09-01 Cetus Corporation Process for simultaneously detecting multiple antigens using dual sandwich immunometric assay
US5011771A (en) * 1984-04-12 1991-04-30 The General Hospital Corporation Multiepitopic immunometric assay
US4563417A (en) * 1984-08-31 1986-01-07 Miles Laboratories, Inc. Nucleic acid hybridization assay employing antibodies to intercalation complexes
US5962223A (en) * 1984-12-13 1999-10-05 The Perkin-Elmer Corporation Detection of specific sequences in nucleic acids
US4824775A (en) * 1985-01-03 1989-04-25 Molecular Diagnostics, Inc. Cells labeled with multiple Fluorophores bound to a nucleic acid carrier
US5026653A (en) * 1985-04-02 1991-06-25 Leeco Diagnostic, Inc. Scavenger antibody mixture and its use for immunometric assay
US5656731A (en) * 1987-10-15 1997-08-12 Chiron Corporation Nucleic acid-amplified immunoassay probes
US4988617A (en) * 1988-03-25 1991-01-29 California Institute Of Technology Method of detecting a nucleotide change in nucleic acids
US5830670A (en) * 1988-12-21 1998-11-03 The General Hospital Corporation Neural thread protein gene expression and detection of Alzheimer's disease
US6143508A (en) * 1989-06-29 2000-11-07 Rhone-Poulenc Rorer Pharmaceuticals Inc. Device and process for cell capture and recovery
US5876976A (en) * 1990-05-01 1999-03-02 Amgen Inc. Method for reducing carryover contamination in an amplification procedure
US5759773A (en) * 1993-01-15 1998-06-02 The Public Health Research Institute Of The City Of New York, Inc. Sensitive nucleic acid sandwich hybridization assay
US5652107A (en) * 1993-01-15 1997-07-29 The Public Health Research Institute Of The City Of New York, Inc. Diagnostic assays and kits for RNA using RNA binary probes and a ribozyme ligase
US5985548A (en) * 1993-02-04 1999-11-16 E. I. Du Pont De Nemours And Company Amplification of assay reporters by nucleic acid replication
US5384255A (en) * 1993-06-21 1995-01-24 Rappaport Family Institute For Research In The Medical Sciences Ubiquitin carrier enzyme E2-F1, purification, production, and use
US5635602A (en) * 1993-08-13 1997-06-03 The Regents Of The University Of California Design and synthesis of bispecific DNA-antibody conjugates
US5849878A (en) * 1993-08-13 1998-12-15 The Regents Of The University Of California Design and synthesis of bispecific reagents: use of double stranded DNAs as chemically and spatially defined cross-linkers
US5415839A (en) * 1993-10-21 1995-05-16 Abbott Laboratories Apparatus and method for amplifying and detecting target nucleic acids
US6235472B1 (en) * 1994-02-16 2001-05-22 Ulf Landegren Nucleic acid detecting reagent
US5693764A (en) * 1994-03-11 1997-12-02 The University Of Kentucky Research Foundation Nucleotide or nucleoside photoaffinity compound modified antibodies, methods for their manufacture and use thereof as diagnostics and therapeutics
US5814492A (en) * 1995-06-07 1998-09-29 Abbott Laboratories Probe masking method of reducing background in an amplification reaction
US5667974A (en) * 1995-06-07 1997-09-16 Abbott Laboratories Method for detecting nucleic acid sequences using competitive amplification
US6878515B1 (en) * 1995-06-16 2005-04-12 Ulf Landegren Ultrasensitive immunoassays
US5780231A (en) * 1995-11-17 1998-07-14 Lynx Therapeutics, Inc. DNA extension and analysis with rolling primers
US5804384A (en) * 1996-12-06 1998-09-08 Vysis, Inc. Devices and methods for detecting multiple analytes in samples
US5812272A (en) * 1997-01-30 1998-09-22 Hewlett-Packard Company Apparatus and method with tiled light source array for integrated assay sensing
US5919626A (en) * 1997-06-06 1999-07-06 Orchid Bio Computer, Inc. Attachment of unmodified nucleic acids to silanized solid phase surfaces
US6558928B1 (en) * 1998-03-25 2003-05-06 Ulf Landegren Rolling circle replication of padlock probes
US7074564B2 (en) * 1998-03-25 2006-07-11 Ulf Landegren Rolling circle replication of padlock probes
US20020064779A1 (en) * 2000-02-18 2002-05-30 Ulf Landegren Methods and kits for proximity probing
US20030207300A1 (en) * 2000-04-28 2003-11-06 Matray Tracy J. Multiplex analytical platform using molecular tags
US6511809B2 (en) * 2000-06-13 2003-01-28 E. I. Du Pont De Nemours And Company Method for the detection of an analyte by means of a nucleic acid reporter
US20020051986A1 (en) * 2000-06-13 2002-05-02 Luis Baez Method for the detection of an analyte by means of a nucleic acid reporter
US20040038200A1 (en) * 2000-07-11 2004-02-26 Wilson Stuart Mark Distinguishing molecular forms
US20030148335A1 (en) * 2001-10-10 2003-08-07 Li Shen Detecting targets by unique identifier nucleotide tags
US20050287528A1 (en) * 2002-04-04 2005-12-29 Mount Sinai Hospital Methods for detecting ovarian cancer
US20050009050A1 (en) * 2003-04-18 2005-01-13 James Nadeau Immuno-amplification
US20040234966A1 (en) * 2003-05-23 2004-11-25 Applera Corporation Ionic liquid apparatus and method for biological samples

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080305479A1 (en) * 2006-12-05 2008-12-11 Sequenom, Inc. Detection and quantification of biomolecules using mass spectrometry
US20090111712A1 (en) * 2006-12-05 2009-04-30 Sequenom, Inc. Detection and quantification of biomolecules using mass spectrometry
US7902345B2 (en) 2006-12-05 2011-03-08 Sequenom, Inc. Detection and quantification of biomolecules using mass spectrometry
US20110160093A1 (en) * 2006-12-05 2011-06-30 Sequenom, Inc. Detection and quantification of biomolecules using mass spectrometry
US8133701B2 (en) 2006-12-05 2012-03-13 Sequenom, Inc. Detection and quantification of biomolecules using mass spectrometry
US8383795B2 (en) 2006-12-05 2013-02-26 Sequenom, Inc. Detection and quantification of biomolecules using mass spectrometry
US9051608B2 (en) 2006-12-05 2015-06-09 Agena Bioscience, Inc. Detection and quantification of biomolecules using mass spectrometry
US9404150B2 (en) 2007-08-29 2016-08-02 Sequenom, Inc. Methods and compositions for universal size-specific PCR
CN103454427A (en) * 2012-06-03 2013-12-18 河北省健海生物芯片技术有限责任公司 Method for detecting trace protein in blood by utilizing antibody-nucleic acid combined amplification technology
WO2014210376A1 (en) * 2013-06-27 2014-12-31 The Board Of Trustees Of The Leland Stanford Junior University Dna-conjugated antibodies for improved antibody affinity and reduced antibody cross reactivity

Also Published As

Publication number Publication date Type
DE69614539T2 (en) 2002-05-23 grant
DE69614539D1 (en) 2001-09-20 grant
JPH11508040A (en) 1999-07-13 application
CA2224674A1 (en) 1997-01-03 application
EP0832431B1 (en) 2001-08-16 grant
EP0832431A1 (en) 1998-04-01 application
US6878515B1 (en) 2005-04-12 grant
CA2224674C (en) 2009-02-24 grant
JP4091113B2 (en) 2008-05-28 grant
WO1997000446A1 (en) 1997-01-03 application

Similar Documents

Publication Publication Date Title
Wacker et al. Performance of antibody microarrays fabricated by either DNA-directed immobilization, direct spotting, or streptavidin–biotin attachment: a comparative study
US4894325A (en) Hybridization method for the detection of genetic material
Holmberg et al. The biotin‐streptavidin interaction can be reversibly broken using water at elevated temperatures
US4824775A (en) Cells labeled with multiple Fluorophores bound to a nucleic acid carrier
US5843650A (en) Nucleic acid detection and amplification by chemical linkage of oligonucleotides
US5849478A (en) Blocked-polymerase polynucleotide immunoassay method and kit
US4794073A (en) Detection of nucleic acid hybrids by prolonged chemiluminescence
US5705346A (en) Method for detecting a target nucleic acid by using an interaction of two kinds of reagents
US5846724A (en) Highly specific surface for biological reactions having an exposed ethylenic double bond, process of using the surface, and method for assaying for a molecule using the surface
US20060040286A1 (en) Bio-barcode based detection of target analytes
US6974669B2 (en) Bio-barcodes based on oligonucleotide-modified nanoparticles
US6265169B1 (en) Method based on the use of bacteriophages for the detection biological molecules in biological samples
US20030054356A1 (en) Multiple reporter read-out for bioassays
US20050153354A1 (en) Detection and quantification of analytes in solution using polymers
US5627030A (en) Method of amplification for increasing the sensitivity of detecting nucleic acid-probe target hybrids
US5641630A (en) Method and kit for performing nucleic acid hybridization assays
US4968602A (en) Solution-phase single hybridization assay for detecting polynucleotide sequences
US5273882A (en) Method and kit for performing nucleic acid hybridization assays
US5912124A (en) Padlock probe detection
Niemeyer et al. Oligonucleotide-directed self-assembly of proteins: semisynthetic DNA—streptavidin hybrid molecules as connectors for the generation of macroscopic arrays and the construction of supramolecular bioconjugates
US5858652A (en) Detection and amplification of target nucleic acid sequences
US20040076983A1 (en) Ligand detection method
US5728531A (en) Method of detecting nucleic acid
US20050037397A1 (en) Bio-barcode based detection of target analytes
EP0698792A1 (en) Method for assaying more than one immunological ligand, and assay reagent and kit therefor